When Associate Professor Kyoko Yoshioka-Maeda met adults who discovered late in life that they had hip dysplasia, many described a shock: they hadn't known they were unwell until pain forced them to seek answers. That encounter sparked an ambitious question: could community nurses, equipped with portable ultrasound devices, catch these missed cases before they became lifelong problems? A new trial in Japan suggests the answer is yes.
Developmental dysplasia of the hip (DDH) occurs when a hip socket is too shallow to properly support the thighbone. In infants, it can cause anything from a mildly loose hip to complete dislocation. Left undetected, the condition becomes the most common cause of hip arthritis for people under 50, eventually affecting how people walk, triggering early-onset arthritis, and causing chronic pain and mobility issues. The challenge is that many cases slip through traditional screening, which relies primarily on physical examination during newborn checks. Yoshioka-Maeda and her colleagues at the University of Tokyo decided to test whether bringing ultrasound screening directly into communities—rather than requiring families to travel to hospitals—could catch these hidden cases while easing strain on Japan's stretched pediatric orthopedic system.
The proof came from a trial spanning 2024 and 2025 across three municipalities: two in the southern island prefecture of Okinawa and one in central Aichi Prefecture. Public health nurses and midwives received specialized training in the portable ultrasound device (the iViz air Ver. 5 linear probe by Fujifilm) and the Graf method for diagnosing DDH. They then conducted screenings during routine home visits or at public health centers. The results exceeded expectations: 349 of 365 targeted infants were screened, achieving 95.6% coverage. Pediatric orthopedic surgeons reviewed ultrasound images remotely, successfully classifying 85.8% of them. Most strikingly, 8.7% of the screened infants showed suspected hip dysplasia—including children with no clinical signs or known risk factors who would have been missed by physical examination alone.
This finding matters because it reveals the scale of undetected cases hiding in plain sight. Yoshioka-Maeda noted that based on a nationwide survey, only about 2% of Japanese municipalities currently use ultrasound screening, largely due to workforce constraints and the unequal distribution of pediatric specialists between rural and urban areas. By training community nurses already visiting families for postpartum care, the trial demonstrated a path around those barriers. The portable ultrasound devices, loaned to each municipality, became tools that traveled into homes rather than requiring families to come to hospitals.
The implications ripple outward. Most countries, including Japan, South Korea, and Taiwan, rely on selective screening based on physical exam or family history. Only a handful—Austria, Switzerland, and Mongolia—offer universal ultrasound screening for all newborns, which is far more accurate. This trial suggests a middle ground: embedding comprehensive ultrasound screening into existing community health infrastructure. For Japan, facing a declining number of pediatric orthopedic surgeons, it offers a way to reach more infants without overwhelming specialist services.
Yoshioka-Maeda's journey from meeting late-diagnosed adults to piloting this solution shows how one person's question can reshape how a health system thinks about prevention. The trial, published in the International Journal of Nursing Studies, suggests that the answer to catching hip dysplasia early may lie not in building more hospitals, but in trusting the nurses already at families' doors with the right training and tools.